| ID | Sequence | Length | GC content |
|---|---|---|---|
| CUUCAAAGGUUGGCUUGCCACCUGAAGCAGCCACUGCCCAGGGGGUGCA… | 1245 nt | 0.5928 | |
| CUUCAAAGGUUGGCUUGCCACCUGAAGCAGCCACUGCCCAGGGGGUGCA… | 1338 nt | 0.5807 | |
| CUUCAAAGGUUGGCUUGCCACCUGAAGCAGCCACUGCCCAGGGGGUGCA… | 1218 nt | 0.5936 | |
| CUUCAAAGGUUGGCUUGCCACCUGAAGCAGCCACUGCCCAGGGGGUGCA… | 1065 nt | 0.5934 | |
| GUUGCUGAGGAAAGAGUGGAGGAGGCUGUUGACCCGUGUGUGUCCCCAU… | 1196 nt | 0.5686 | |
| GUUGCUGAGGAAAGAGUGGAGGAGGCUGUUGACCCGUGUGUGUCCCCAU… | 1284 nt | 0.5576 | |
| CAGAGUGUGACAGAAGAGAGGCAGCUCUACACCCCUUGCUUGCAAUUCU… | 1321 nt | 0.5435 |
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. This receptor transduces signals that lead to the activation of NF-kappaB and MAPK8/JNK. Adaptor proteins TRAF2 and TRAF5 have been shown to mediate the signaling process of this receptor. CD27-binding protein (SIVA), a proapoptotic protein, can bind to this receptor and is thought to play an important role in the apoptosis induced by this receptor. [provided by RefSeq, Jul 2008]
A study in humans identified the CD27 as a core diagnostic and prognostic biomarker for sepsis, with its highest odds and hazard ratios indicating a strong association with clinically overt sepsis [Li et al. DOI:10.3389/fimmu.2025.1700704]. Its expression was localized to T cells, and its diagnostic performance was validated across seven machine-learning models, achieving area under the curve values exceeding 0.9, though its expression did not show a statistically significant correlation with survival rate in the analysis performed.